165 related articles for article (PubMed ID: 12359847)
1. Young cooperative oncology group spans southeast Asia, Australia.
Wang L
J Natl Cancer Inst; 2002 Oct; 94(19):1426-9. PubMed ID: 12359847
[No Abstract] [Full Text] [Related]
2. Ethnic differences in drug metabolism and toxicity from chemotherapy.
Phan VH; Moore MM; McLachlan AJ; Piquette-Miller M; Xu H; Clarke SJ
Expert Opin Drug Metab Toxicol; 2009 Mar; 5(3):243-57. PubMed ID: 19331590
[TBL] [Abstract][Full Text] [Related]
3. How not to treat cancer.
Schilsky RL
Lancet Oncol; 2008 Jun; 9(6):504-5. PubMed ID: 18510981
[No Abstract] [Full Text] [Related]
4. Asia plans first cancer network.
Cyranoski D
Nature; 2007 Dec; 450(7171):772-3. PubMed ID: 18063963
[No Abstract] [Full Text] [Related]
5. Genetic profiling can predict chemotherapy side effects and treatment response.
Expert Rev Mol Diagn; 2003 Jul; 3(4):406-7. PubMed ID: 12877380
[No Abstract] [Full Text] [Related]
6. Cancer pharmacogenetics.
Marsh S
Methods Mol Biol; 2008; 448():437-46. PubMed ID: 18370241
[TBL] [Abstract][Full Text] [Related]
7. Perspective on the application of pharmacogenomics in the treatment of cancer.
Wolf R
Pharmacogenomics; 2009 Apr; 10(4):527-9. PubMed ID: 19374511
[No Abstract] [Full Text] [Related]
8. [Pharmacogenetics in fluoropyrimidine chemotherapy].
Ichikawa W; Sasaki Y
Gan To Kagaku Ryoho; 2008 Feb; 35(2):178-81. PubMed ID: 18281752
[TBL] [Abstract][Full Text] [Related]
9. Pharmacogenetics in cancer treatment.
Nagasubramanian R; Innocenti F; Ratain MJ
Annu Rev Med; 2003; 54():437-52. PubMed ID: 12525681
[TBL] [Abstract][Full Text] [Related]
10. Challenges in the development and use of pharmacogenomic markers in oncology.
Innocenti F
J Support Oncol; 2007 Jan; 5(1):15-6. PubMed ID: 17265781
[No Abstract] [Full Text] [Related]
11. Pharmacogenetics in oncology: a promising field.
Houtsma D; Guchelaar HJ; Gelderblom H
Curr Pharm Des; 2010; 16(2):155-63. PubMed ID: 20205661
[TBL] [Abstract][Full Text] [Related]
12. Pharmacogenetics in the cancer clinic: from candidate gene studies to next-generation sequencing.
Guchelaar HJ; Gelderblom H; van der Straaten T; Schellens JH; Swen JJ
Clin Pharmacol Ther; 2014 Apr; 95(4):383-5. PubMed ID: 24448475
[TBL] [Abstract][Full Text] [Related]
13. New perspectives in personalised medicine for ethnicity in cancer: population pharmacogenomics and pharmacometrics.
Nair S; LLerena A
Drug Metab Pers Ther; 2018 Jun; 33(2):61-64. PubMed ID: 29688886
[No Abstract] [Full Text] [Related]
14. Cancer pharmacogenetics: polymorphisms, pathways and beyond.
Ulrich CM; Robien K; McLeod HL
Nat Rev Cancer; 2003 Dec; 3(12):912-20. PubMed ID: 14740638
[No Abstract] [Full Text] [Related]
15. Update on pharmacogenetics in cancer chemotherapy.
Innocenti F; Ratain MJ
Eur J Cancer; 2002 Mar; 38(5):639-44. PubMed ID: 11916544
[TBL] [Abstract][Full Text] [Related]
16. THE DISTRIBUTION OF THE GROUP SPECIFIC COMPONENT (GC) IN SELECTED POPULATIONS IN SOUTH EAST ASIA AND OCEANIA.
KIRK RL; CLEVE H; BEARN AG
Acta Genet Stat Med; 1963; 13():140-9. PubMed ID: 14047123
[No Abstract] [Full Text] [Related]
17. Pharmacogenetics of the neurodevelopmental impact of anticancer chemotherapy.
Robaey P; Krajinovic M; Marcoux S; Moghrabi A
Dev Disabil Res Rev; 2008; 14(3):211-20. PubMed ID: 18924160
[TBL] [Abstract][Full Text] [Related]
18. Pharmacogenetic determinants of anti-cancer drug activity and toxicity.
Danesi R; De Braud F; Fogli S; Di Paolo A; Del Tacca M
Trends Pharmacol Sci; 2001 Aug; 22(8):420-6. PubMed ID: 11479005
[TBL] [Abstract][Full Text] [Related]
19. Pharmacogenomics in Asia: a systematic review on current trends and novel discoveries.
Ang HX; Chan SL; Sani LL; Quah CB; Brunham LR; Tan BOP; Winther MD
Pharmacogenomics; 2017 Jun; 18(9):891-910. PubMed ID: 28594321
[TBL] [Abstract][Full Text] [Related]
20. Infusion of pharmacogenetics into cancer care.
Prows CA
Semin Oncol Nurs; 2011 Feb; 27(1):45-53. PubMed ID: 21255712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
